International Stem Cell Corp (ISCO)
0.097
-0.01
(-11.01%)
USD |
OTCM |
May 03, 16:00
International Stem Cell 1 Year Total Returns (Daily): -39.38% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -39.38% |
May 02, 2024 | -31.88% |
May 01, 2024 | -37.81% |
April 30, 2024 | -38.75% |
April 29, 2024 | -38.75% |
April 26, 2024 | -57.79% |
April 25, 2024 | -63.89% |
April 24, 2024 | -63.89% |
April 23, 2024 | -60.44% |
April 22, 2024 | -60.44% |
April 19, 2024 | -60.04% |
April 18, 2024 | -60.04% |
April 17, 2024 | -50.90% |
April 16, 2024 | -60.50% |
April 15, 2024 | -50.51% |
April 12, 2024 | -39.97% |
April 11, 2024 | -39.97% |
April 10, 2024 | -65.40% |
April 09, 2024 | -70.32% |
April 08, 2024 | -54.34% |
April 05, 2024 | -54.34% |
April 04, 2024 | -52.36% |
April 03, 2024 | -44.44% |
April 02, 2024 | -48.06% |
April 01, 2024 | -42.97% |
Date | Value |
---|---|
March 28, 2024 | -45.97% |
March 27, 2024 | -45.97% |
March 26, 2024 | -67.84% |
March 25, 2024 | -47.37% |
March 22, 2024 | -72.58% |
March 21, 2024 | -54.97% |
March 20, 2024 | -54.97% |
March 19, 2024 | -66.67% |
March 18, 2024 | -59.52% |
March 15, 2024 | -60.47% |
March 14, 2024 | -48.84% |
March 13, 2024 | -48.84% |
March 12, 2024 | -52.65% |
March 11, 2024 | -52.65% |
March 08, 2024 | -54.64% |
March 07, 2024 | -56.99% |
March 06, 2024 | -56.99% |
March 05, 2024 | -56.99% |
March 04, 2024 | -56.99% |
March 01, 2024 | -57.83% |
February 29, 2024 | -61.25% |
February 28, 2024 | -61.25% |
February 27, 2024 | -63.18% |
February 26, 2024 | -63.18% |
February 23, 2024 | -60.05% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-78.57%
Minimum
Jun 27 2023
87.18%
Maximum
Apr 07 2021
-34.04%
Average
-43.04%
Median
Aug 07 2019
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -15.65% |
Perspective Therapeutics Inc | 196.0% |
Protalix BioTherapeutics Inc | -63.81% |
Electromed Inc | 78.40% |
Armata Pharmaceuticals Inc | 61.69% |